DSGX
The Descartes Systems Group Inc.
DSGX has a slight edge over SNDK overall, supported by lower modeled downside and stronger valuation.
SNDK
Sandisk Corporation
SNDK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
DSGX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
DSGX's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
DSGX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 37x | $95.47 | — |
| Current | 43x | $95.47 | — |
| Cheap | 56x | $123 | +29% |
| Fair | 68x | $150 | +57% |
| Expensive | 110x | $242 | +154% |
Historical ranges are pointers, not guarantees.
DSGX's PE is in its cheap range at 43x. If earnings grow as analysts expect, today's price would be 37x next year's earnings.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over DSGX in the historical PE scenario, which offers more potential upside but is not a forecast.
DSGX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for DSGX, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
DSGX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +17% |
| Q3 2026 | $2.20 | +30% |
| Q2 2026 | $2.06 | +24% |
| Q1 2026 | $1.91 | +16% |
| Q4 2025 | $1.77 | +11% |
| Q3 2025 | $1.69 | +15% |
| Q2 2025 | $1.66 | +19% |
| Q1 2025 | $1.65 | +24% |
| Q4 2024 | $1.59 | +21% |
DSGX's earnings per share have climbed steadily: $2.20 over the past year, up 30% from the year before, and higher year over year every quarter since late 2020.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over DSGX in the latest year-over-year earnings comparison.
DSGX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.1M | +12% |
| Q2 2026 | $193.6M | +15% |
| Q1 2026 | $194.6M | +16% |
| Q4 2025 | $185.8M | +10% |
| Q3 2025 | $179.8M | +10% |
| Q2 2025 | $168.7M | +11% |
| Q1 2025 | $167.5M | +13% |
| Q4 2024 | $168.8M | +17% |
DSGX's revenue has grown year over year every quarter since late 2020: $201M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 33% | +6.4 points |
| Q2 2026 | 33% | +5.5 points |
| Q1 2026 | 33% | +5 points |
| Q4 2025 | 33% | +6 points |
| Q3 2025 | 27% | -1.3 points |
| Q2 2025 | 27% | -0.6 points |
| Q1 2025 | 28% | +3.1 points |
| Q4 2024 | 27% | +4.7 points |
DSGX's operating margin was 33% last quarter, up 6.4 points from the same quarter a year ago, near the top of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over DSGX on profitability, with a higher operating margin.
DSGX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $78.9M | +27% |
| Q2 2026 | $73.2M | +41% |
| Q1 2026 | $75.9M | +30% |
| Q4 2025 | $71.5M | +22% |
| Q3 2025 | $62.1M | +88% |
| Q2 2025 | $51.7M | -15% |
| Q1 2025 | $58.6M | +16% |
| Q4 2024 | $58.8M | +7.8% |
DSGX has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
DSGX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -334K shares |
| 1 year | -0.6% | -530K shares |
| 3 years | +0.3% | +277K shares |
| 5 years | +1.1% | +932K shares |
| Available history | +2% | +1.7M shares |
DSGX has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $24.2M |
| Q2 2026 | $21M |
| Q1 2026 | $911,573 |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
DSGX spent $46M buying back its own shares over the past year, after none the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
DSGX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.2x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
DSGX has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
DSGX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.7 | Neutral |
| Stochastic | 89.2 | Overbought |
DSGX's weekly RSI is 67 (neutral) and its Stochastic is 89 (overbought).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
DSGX PE vs Technology Sector
| Metric | DSGX | Sector median | Relative |
|---|---|---|---|
| PE | 43x | 28x | 56% above |
| PE % | 11 | 35 | 24 pts below |
DSGX is trading at 43x earnings, a 56% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over DSGX on valuation relative to its sector.
DSGX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $87.8 | 8.7% above |
| 20 week MA | $80.7 | 18% above |
| 50 week MA | $77.5 | 23% above |
| 100 week MA | $90.4 | 5.6% above |
| 200 week MA | $88.9 | 7.5% above |
DSGX has stronger trend alignment. DSGX is above 5 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
DSGX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.7 | $59.7 | +40% |
| 2021 | $59.7 | $80.9 | +36% |
| 2022 | $80.9 | $68.5 | -15% |
| 2023 | $68.5 | $84.1 | +23% |
| 2024 | $84.1 | $114.0 | +36% |
| 2025 | $114.0 | $89.4 | -22% |
| 2026 YTD | $89.4 | $95.5 | +6.7% |
DSGX has finished higher in four of the last six years. It's up 6.7% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over DSGX on returns for 2026, with the stronger performance.